Skip to main content
Clinical Trials/IRCT20220901055848N1
IRCT20220901055848N1
Recruiting
Phase 3

Comparison of the effectiveness of duloxetine and nortriptyline in the treatment of pain in rheumatoid arthritis patients

Conditionspain.

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
pain.
Sponsor
Shahid Beheshti University of Medical Sciences
Enrollment
54
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Confirmation of the clinical diagnosis of mild to moderate Rheumatoid Arthritis by a rheumatologist
  • Presence of RF or AntiCCP in the serum of patients
  • Patients under treatment with methotrexate, prednisolone and hydroxychloroquine
  • Articular involvement without extra\-articular involvement
  • Age range from 18 to 70 years
  • Pain complaint
  • Consent to participate in the study

Exclusion Criteria

  • The presence of major psychiatric disorders, including depression, anxiety disorders, bipolar, schizophrenia, abuse of any substance and medication.
  • History of allergy to Duloxetine or Nortriptyline
  • Pregnancy, breastfeeding, or planning to become pregnant in the near future
  • Refusing to consent to receive treatment according to the instructions of this protocol

Outcomes

Primary Outcomes

Not specified

Similar Trials